Maia BiotechnologyMAIA
13F holders, Q1 2026 (March 31)33holders +7
11new positions
6sold out
$1.40avg. 13F price*
At the end of Q1 2026, 33 institutions reported holding Maia Biotechnology Inc. (MAIA) in their 13F filings, up 7 from Q4 2025. 11 opened new positions and 6 sold out. The largest holders were Solas Capital Management, LLC ($6.0M), Alyeska Investment Group, L.P. ($3.5M) and Vanguard Capital Management LLC ($2.9M).
- Company
- Maia Biotechnology Inc.
- CUSIP
- 552641102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $12.8M |
| Exits | 6 | $160K |
All 13F filers, Q4 2025 → Q1 2026: 9,611,761 shares bought and 106,254 shares sold, net +9,505,507 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Solas Capital Management, LLC | 3.46% | New | 4,297,004 | $6.0M |
| Alyeska Investment Group, L.P. | 0.01% | New | 2,500,000 | $3.5M |
| Vanguard Capital Management LLC | 0.00% | — | 2,074,045 | $2.9M |
| 683 Capital Management, LLC | 0.15% | New | 1,066,666 | $1.5M |
| Centric Wealth Management | 0.22% | Add +35.9% | 796,723 | $1.1M |
| Cable Car Capital, LP | 0.39% | New | 648,503 | $908K |
| Bleichroeder LP | 0.12% | New | 500,000 | $700K |
| Geode Capital Management, LLC | 0.00% | Add +21.5% | 360,481 | $505K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 199,314 | $279K |
| State Street Corp. | 0.00% | Add +83.9% | 138,950 | $195K |
| BlackRock, Inc. | 0.00% | Add +19.3% | 127,978 | $179K |
| Corsair Capital Management, L.P. | 0.02% | New | 100,000 | $140K |
| Northern Trust Corp. | 0.00% | Add +34.6% | 52,539 | $74K |
| UBS Group AG | 0.00% | Add +2292.5% | 51,917 | $73K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 36,000 | $50K |
| PVG Asset Management Corp. | 0.03% | New | 34,135 | $46K |
| Creative Planning | 0.00% | Reduce -0.8% | 28,602 | $40K |
| Ritholtz Wealth Management | 0.00% | No change | 23,071 | $32K |
| O'shaughnessy Asset Management, LLC | 0.00% | New | 20,071 | $28K |
| Centerpoint Advisory Group | 0.02% | No change | 15,730 | $22K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 14,800 | $20K |
| Morgan Stanley | 0.00% | Add +1285.9% | 13,859 | $19K |
| Vanguard Global Advisers, LLC | 0.00% | — | 11,401 | $16K |
| Catalyst Funds Management Pty Ltd | 0.00% | New | 10,800 | $15K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 10,620 | $15K |
| Osaic Holdings, Inc. | 0.00% | No change | 8,334 | $12K |
| Daytona Street Capital LLC | 0.01% | No change | 7,500 | $10K |
| Curio Wealth, LLC | 0.00% | No change | 2,000 | $3K |
| MAI Capital Management | 0.00% | No change | 675 | $945 |
| Jones Financial Companies LLLP | 0.00% | No change | 228 | $299 |
| Citigroup Inc. | 0.00% | Reduce -98.7% | 22 | $31 |
| FMR LLC | 0.00% | New | 2 | $2 |
| Royal Bank of Canada | 0.00% | New | 268 | $0 |
"% of holder's portfolio" is MAIA's weight in each manager's 13F, not the share of Maia Biotechnology Inc. the manager owns.